Salah S Al-Zaiti1, James A Fallavollita2, John M Canty3, Mary G Carey4. 1. The University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: ssa33@pitt.edu. 2. VA WNY Health Care System at Buffalo, Buffalo, NY, USA; Clinical Translational Research Center, Buffalo, NY, USA; Department of Medicine, University at Buffalo, Buffalo, NY, USA. 3. VA WNY Health Care System at Buffalo, Buffalo, NY, USA; Clinical Translational Research Center, Buffalo, NY, USA; Department of Medicine, University at Buffalo, Buffalo, NY, USA; Department of Physiology & Biophysics, University at Buffalo, Buffalo, NY, USA; Department of Biomedical Engineering, University at Buffalo, Buffalo, NY, USA. 4. University of Rochester Medical Center, Rochester, NY, USA.
Abstract
BACKGROUND: Simple and reliable ECG marker(s) for sudden cardiac arrest (SCA) could be very useful in assessing high-risk populations. Since ischemic repolarization abnormalities in the left ventricular (LV) apex are strongly correlated with discordant T waves in lead aVR, we sought to evaluate the clinical and prognostic significance of this feature in ischemic cardiomyopathy. METHODS: The PAREPET trial enrolled patients with ischemic cardiomyopathy eligible for a primary prevention implantable cardiac defibrillator (ICD). Those with persistent pacing or left bundle branch block were excluded. Amplitudes of T/aVR were automatically computed from median ECG beats at enrollment and endpoints were blindly adjudicated. RESULTS: The sample was mainly composed of older men (n=138, age 65±12, 91% male, EF 29±9%). At enrollment, amplitude of T/aVR significantly correlated with EF, indexed LV end-diastolic volume, B-type natriuretic peptide (BNP), regional scar volume, and PET-quantified denervated myocardium. After a median follow up of 4.2years, there were 23 (17%) adjudicated SCA. In multivariate analysis, the presence of discordant T/aVR (>0mm, n=42, 30%) was a significant and independent predictor of SCA (hazard ratio 2.0 [95% CI 1.0-4.9]) and cardiac death (hazard ratio 1.9 [95% CI 1.0-3.7]). CONCLUSIONS: In subjects with ischemic cardiomyopathy, discordant T waves in lead aVR are associated with high-risk clinical parameters including lower ejection fraction, greater ventricular volume, higher BNP, and more denervated myocardium. Furthermore, discordant T/aVR remained an independent predictor of SCA and cardiovascular mortality even after accounting for these prognostic factors.
BACKGROUND: Simple and reliable ECG marker(s) for sudden cardiac arrest (SCA) could be very useful in assessing high-risk populations. Since ischemic repolarization abnormalities in the left ventricular (LV) apex are strongly correlated with discordant T waves in lead aVR, we sought to evaluate the clinical and prognostic significance of this feature in ischemic cardiomyopathy. METHODS: The PAREPET trial enrolled patients with ischemic cardiomyopathy eligible for a primary prevention implantable cardiac defibrillator (ICD). Those with persistent pacing or left bundle branch block were excluded. Amplitudes of T/aVR were automatically computed from median ECG beats at enrollment and endpoints were blindly adjudicated. RESULTS: The sample was mainly composed of older men (n=138, age 65±12, 91% male, EF 29±9%). At enrollment, amplitude of T/aVR significantly correlated with EF, indexed LV end-diastolic volume, B-type natriuretic peptide (BNP), regional scar volume, and PET-quantified denervated myocardium. After a median follow up of 4.2years, there were 23 (17%) adjudicated SCA. In multivariate analysis, the presence of discordant T/aVR (>0mm, n=42, 30%) was a significant and independent predictor of SCA (hazard ratio 2.0 [95% CI 1.0-4.9]) and cardiac death (hazard ratio 1.9 [95% CI 1.0-3.7]). CONCLUSIONS: In subjects with ischemic cardiomyopathy, discordant T waves in lead aVR are associated with high-risk clinical parameters including lower ejection fraction, greater ventricular volume, higher BNP, and more denervated myocardium. Furthermore, discordant T/aVR remained an independent predictor of SCA and cardiovascular mortality even after accounting for these prognostic factors.
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: James A Fallavollita; Brendan M Heavey; Andrew J Luisi; Suzanne M Michalek; Sunil Baldwa; Terry L Mashtare; Alan D Hutson; Robert A Dekemp; Michael S Haka; Munawwar Sajjad; Thomas R Cimato; Anne B Curtis; Michael E Cain; John M Canty Journal: J Am Coll Cardiol Date: 2013-09-25 Impact factor: 24.094
Authors: Ismo Anttila; Kjell Nikus; Tuomo Nieminen; Antti Jula; Veikko Salomaa; Antti Reunanen; Markku Sakari Nieminen; Terho Lehtimäki; Vesa Virtanen; Mika Kähönen Journal: Am J Cardiol Date: 2011-09-08 Impact factor: 2.778
Authors: Alfred E Buxton; Kerry L Lee; Gail E Hafley; Luis A Pires; John D Fisher; Michael R Gold; Mark E Josephson; Michael H Lehmann; Eric N Prystowsky Journal: J Am Coll Cardiol Date: 2007-09-04 Impact factor: 24.094
Authors: Niek Verweij; Irene Mateo Leach; Aaron Isaacs; Dan E Arking; Joshua C Bis; Tune H Pers; Marten E Van Den Berg; Leo-Pekka Lyytikäinen; Phil Barnett; Xinchen Wang; Elsayed Z Soliman; Cornelia M Van Duijn; Mika Kähönen; Dirk J Van Veldhuisen; Jan A Kors; Olli T Raitakari; Claudia T Silva; Terho Lehtimäki; Hans L Hillege; Joel N Hirschhorn; Laurie A Boyer; Wiek H Van Gilst; Alvaro Alonso; Nona Sotoodehnia; Mark Eijgelsheim; Rudolf A De Boer; Paul I W De Bakker; Lude Franke; Pim Van Der Harst Journal: Hum Mol Genet Date: 2016-03-08 Impact factor: 6.150